Extraordinary general meeting in Newbury Pharmaceuticals AB (publ)
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Extraordinary general meeting in Newbury Pharmaceuticals AB (publ) (the ”Company”) was held on 31 July 2024. Full information and documentation regarding the resolutions at the meeting are available at the Company’s website, www.newburypharma.com. All resolutions made at the meeting correspond to the proposals presented in the notice.
Election of board members
The meeting resolved that the board of directors shall comprise of six members with no deputies and to elect Ramon Vila Ramos and Ivailo S. Georgiev as new members of the board of directors for the period until the end of the next annual general meeting.
Resolution regarding an incentive program, comprising a directed issue of warrants
The meeting resolved, in accordance with the shareholder proposal, on an incentive program comprising a directed issue of a maximum of 1,000,000 warrants to the board members Andreas Hedskog, Anil Okay, Johan Strömqvist and to Ramon Vila Ramos and Ivailo S. Georgiev who were elected as board members at the extraordinary general meeting. The issue of warrants will be made free of any consideration. Each participant shall have the right to receive a maximum of 200,000 warrants. Each participant has undertaken to waive its right to such board renumeration which was resolved by the 2024 annual general meeting.
Each warrant entitles the holder during the period from 1 September 2028 up to and including 30 November 2028 to subscribe for one (1) new share in the Company at a subscription price of SEK 5 per share.